LOU SILVERMAN - 23 Jun 2023 Form 4 Insider Report for Oncocyte Corp (OCX)

Role: Director
Signature: /s/ Lou Silverman
Issuer symbol: OCX
Transactions as of: 23 Jun 2023
Net transactions value: $0
Form type: 4
Filing time: 27 Jun 2023, 21:30:09 UTC
Previous filing: 09 Dec 2022
Next filing: 03 Jul 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCX	Common Stock, no par value	Award	$0	+25,000	+399%	$0.000000	31,270	23 Jun 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCX	Option to Purchase Common Stock	Award	$0	+112,500		$0.000000	112,500	23 Jun 2023	Common Stock	112,500	$0.2000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
F2	Options shall vest one year from the date of grant, subject to the Reporting Person's continued service as a director of the Issuer from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.